Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort
- PMID: 29025891
- DOI: 10.1183/13993003.00853-2017
Impact and associations of eosinophilic inflammation in COPD: analysis of the AERIS cohort
Abstract
Eosinophilic inflammation in chronic obstructive pulmonary disease (COPD) predicts response to treatment, especially corticosteroids. We studied the nature of eosinophilic inflammation in COPD prospectively to examine the stability of this phenotype and its dynamics across exacerbations, and its associations with clinical phenotype, exacerbations and infection.127 patients aged 40-85 years with moderate to very severe COPD underwent repeated blood and sputum sampling at stable visits and within 72 h of exacerbation for 1 year.Blood eosinophils ≥2% was prevalent at baseline, and predicted both predominantly raised stable-state eosinophils across the year (area under the curve 0.841, 95% CI 0.755-0.928) and increased risk of eosinophilic inflammation at exacerbation (OR 9.16; p<0.001). Eosinophils ≥2% at exacerbation and eosinophil predominance at stable visits were associated with a lower risk of bacterial presence at exacerbation (OR 0.49; p=0.049 and OR 0.25; p=0.065, respectively). Bacterial infection at exacerbation was highly seasonal (winter versus summer OR 4.74; p=0.011) in predominantly eosinophilic patients.Eosinophilic inflammation is a common and stable phenotype in COPD. Blood eosinophil counts in the stable state can predict the nature of inflammation at future exacerbations, which when combined with an understanding of seasonal variation provides the basis for the development of new treatment paradigms for this important condition.
Copyright ©ERS 2017.
Conflict of interest statement
Conflict of interest: Disclosures can be found alongside this article at erj.ersjournals.com
Comment in
-
Eosinophilic Chronic Obstructive Pulmonary Disease: Implications for Exacerbations, Readmissions, and Treatment.Am J Respir Crit Care Med. 2019 Jan 1;199(1):110-112. doi: 10.1164/rccm.201802-0328RR. Am J Respir Crit Care Med. 2019. PMID: 30281319 No abstract available.
Similar articles
-
Peripheral blood eosinophils: a surrogate marker for airway eosinophilia in stable COPD.Int J Chron Obstruct Pulmon Dis. 2016 Jul 1;11:1495-504. doi: 10.2147/COPD.S100338. eCollection 2016. Int J Chron Obstruct Pulmon Dis. 2016. PMID: 27445469 Free PMC article.
-
Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations.Thorax. 2018 May;73(5):422-430. doi: 10.1136/thoraxjnl-2017-210408. Epub 2018 Jan 31. Thorax. 2018. PMID: 29386298 Free PMC article.
-
The association between eosinophilic exacerbation and eosinophilic levels in stable COPD.BMC Pulm Med. 2021 Mar 2;21(1):74. doi: 10.1186/s12890-021-01443-4. BMC Pulm Med. 2021. PMID: 33653314 Free PMC article.
-
Exacerbations of chronic obstructive pulmonary disease.Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5. Respir Care. 2003. PMID: 14651761 Review.
-
Eosinophils in COPD-Current Concepts and Clinical Implications.J Allergy Clin Immunol Pract. 2020 Sep;8(8):2565-2574. doi: 10.1016/j.jaip.2020.03.017. Epub 2020 Apr 3. J Allergy Clin Immunol Pract. 2020. PMID: 32251737 Review.
Cited by
-
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease.Am J Respir Crit Care Med. 2020 Sep 1;202(5):660-671. doi: 10.1164/rccm.201912-2384PP. Am J Respir Crit Care Med. 2020. PMID: 32186896 Free PMC article. Review. No abstract available.
-
Angiogenesis, Lymphangiogenesis, and Inflammation in Chronic Obstructive Pulmonary Disease (COPD): Few Certainties and Many Outstanding Questions.Cells. 2022 May 23;11(10):1720. doi: 10.3390/cells11101720. Cells. 2022. PMID: 35626756 Free PMC article. Review.
-
Effects of Roflumilast on Rehospitalization and Mortality in Patients.Chronic Obstr Pulm Dis. 2018 Dec 20;6(1):74-85. doi: 10.15326/jcopdf.6.1.2018.0139. Chronic Obstr Pulm Dis. 2018. PMID: 30775426 Free PMC article.
-
Specialist respiratory outreach: a case-finding initiative for identifying undiagnosed COPD in primary care.NPJ Prim Care Respir Med. 2021 Feb 11;31(1):7. doi: 10.1038/s41533-021-00219-x. NPJ Prim Care Respir Med. 2021. PMID: 33574260 Free PMC article.
-
Impact of radiologically stratified exacerbations: insights into pneumonia aetiology in COPD.Respir Res. 2018 Jul 28;19(1):143. doi: 10.1186/s12931-018-0842-8. Respir Res. 2018. PMID: 30055608 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical